Edgestream Partners L.P. purchased a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 48,310 shares of the company’s stock, valued at approximately $1,718,000. Edgestream Partners L.P. owned approximately 0.09% of Astrana Health at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. Dimensional Fund Advisors LP increased its stake in shares of Astrana Health by 12.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,368,079 shares of the company’s stock valued at $33,545,000 after acquiring an additional 152,267 shares in the last quarter. Bank of America Corp DE raised its holdings in Astrana Health by 13.3% during the first quarter. Bank of America Corp DE now owns 574,729 shares of the company’s stock worth $14,092,000 after buying an additional 67,628 shares during the last quarter. Diamond Hill Capital Management LLC Investment Advisor acquired a new position in Astrana Health during the second quarter worth $22,088,000. Principal Financial Group Inc. lifted its stake in shares of Astrana Health by 15.7% in the first quarter. Principal Financial Group Inc. now owns 265,948 shares of the company’s stock valued at $6,521,000 after buying an additional 36,150 shares in the last quarter. Finally, Bank of New York Mellon Corp bought a new position in shares of Astrana Health in the second quarter valued at $10,902,000. 52.77% of the stock is owned by institutional investors.
Astrana Health Trading Up 0.8%
NASDAQ ASTH opened at $28.90 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.25 and a debt-to-equity ratio of 1.00. The stock’s 50-day simple moving average is $35.64 and its two-hundred day simple moving average is $34.39. Astrana Health, Inc. has a twelve month low of $18.08 and a twelve month high of $51.60. The company has a market capitalization of $1.61 billion, a price-to-earnings ratio of 27.01 and a beta of 1.18.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the stock. Wall Street Zen lowered shares of Astrana Health from a “buy” rating to a “hold” rating in a report on Sunday, August 16th. Oppenheimer began coverage on shares of Astrana Health in a research note on Tuesday, September 15th. They issued an “outperform” rating and a $53.00 price objective for the company. Barclays lifted their target price on shares of Astrana Health from $50.00 to $53.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. Needham & Company LLC boosted their target price on Astrana Health from $41.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, November 6th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astrana Health in a report on Thursday, August 27th. Eight analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Astrana Health has an average rating of “Moderate Buy” and an average target price of $50.38.
View Our Latest Analysis on Astrana Health
Astrana Health Profile
Astrana Health, Inc. is a physician-centric healthcare company that coordinates and delivers care through a network of primary care physicians, specialists and other providers. Its services include primary and specialty care, care coordination, hospital-based care and technology-enabled population health management. The company works with health plans and provider groups under value-based care arrangements, which emphasize coordinating care and managing patients’ health needs across different settings.
Read More
- Five stocks we like better than Astrana Health
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.
